anti-activated protein C mAb (Bayer Pharmaceuticals)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nameanti-activated protein C mAb (Bayer Pharmaceuticals)
Drug Alias NameHAPC-1573
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionFactor Va inhibitors
TargetsCoagulation factor V
Therapy Area/IndicationsHemophilia A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBayer AG
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBayer AG
Active IndicationsN/A
Inactive IndicationsHemophilia A

Other Information

ATC CodeN/A
Related LinksN/A